Comprehensive genomic variation profiling of cervical intraepithelial neoplasia and cervical cancer identifies potential targets for cervical cancer early warning
Jian Huang,Zhaoyang Qian,Yuhua Gong,Yanzhou Wang,Yanfang Guan,Yingxin Han,Xin Yi,Wanqiu Huang,Liyan Ji,Jiajia Xu,Mengyuan Su,Qing Yuan,Shujian Cui,Jinling Zhang,Chaohui Bao,Weilong Liu,Xi Chen,Ming Zhang,Xiaohuan Gao,Renhua Wu,Yinxin Zhang,Huicheng Xu,Shida Zhu,Hongmei Zhu,Ling Yang,Xun Xu,Pingyu Zhou,Zhiqing Liang
DOI: https://doi.org/10.1136/jmedgenet-2018-105745
2018-12-19
Journal of Medical Genetics
Abstract:Background To better understand the pathogenesis of cervical cancer (CC), we systematically analysed the genomic variation and human papillomavirus (HPV) integration profiles of cervical intraepithelial neoplasia (CIN) and CC. Methods We performed whole-genome sequencing or whole-exome sequencing of 102 tumour-normal pairs and human papillomavirus probe capture sequencing of 45 CCs, 44 CIN samples and 25 normal cervical samples, and constructed strict integrated workflow of genomic analysis. Results Mutational analysis identified eight significantly mutated genes in CC including four genes ( FAT1 , MLL3 , MLL2 and FADD ), which have not previously been reported in CC. Targetable alterations were identified in 55.9% of patients. In addition, HPV integration breakpoints occurred in 97.8% of the CC samples, 70.5% of the CIN samples and 42.8% of the normal cervical samples with HPV infection. Integrations of high-risk HPV strains in CCs, including HPV16, 18, 33 and 58, also occurred in the CIN samples. Moreover, gene mutations were detected in 52% of the CIN specimens, and 54.8% of these mutations occurred in genes that also mutated in CCs. Conclusion Our results lay the foundation for a deep understanding of the molecular mechanisms and finding new diagnostic and therapeutic targets of CC.
genetics & heredity